Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use

by Eva Havrdova, Dana Horakova, Ivana Kovarova
Published 2015-01-01

Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients

by Helena Posová, Dana Horáková, Václav Čapek, Tomáš Uher, Zdenka Hrušková, Eva Havrdová
Published 2017-07-01

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.

by Tomas Kalincik, Manuela Vaneckova, Michaela Tyblova, Jan Krasensky, Zdenek Seidl, Eva Havrdova, Dana Horakova
Published 2012-01-01

Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis

by Martin Šubert, Michal Novotný, Tereza Tykalová, Barbora Srpová, Lucie Friedová, Tomáš Uher, Dana Horáková, Jan Rusz
Published 2023-06-01

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis

by Ranjani Ganapathy Subramanian, Dana Horakova, Manuela Vaneckova, Balazs Lorincz, Jan Krasensky, Eva Kubala Havrdova, Tomas Uher
Published 2021-11-01

Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis

by Michael G. Dwyer, Diego Silva, Niels Bergsland, Dana Horakova, Deepa Ramasamy, Jaqueline Durfee, Manuela Vaneckova, Eva Havrdova, Robert Zivadinov
Published 2017-01-01

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy

by Andrea Burgetova, Petr Dusek, Tomas Uher, Manuela Vaneckova, Martin Vejrazka, Romana Burgetova, Dana Horakova, Barbora Srpova, Jan Krasensky, Lukas Lambert
Published 2022-06-01

MRI correlates of disability progression in patients with CIS over 48 months

by Tomas Uher, Dana Horakova, Niels Bergsland, Michaela Tyblova, Deepa P. Ramasamy, Zdenek Seidl, Manuela Vaneckova, Jan Krasensky, Eva Havrdova, Robert Zivadinov
Published 2014-01-01

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study

by Niels Bergsland, Dana Horakova, Michael G. Dwyer, Tomas Uher, Manuela Vaneckova, Michaela Tyblova, Zdenek Seidl, Jan Krasensky, Eva Havrdova, Robert Zivadinov
Published 2018-01-01

Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study

by Robert Zivadinov, Carmen Tekwe, Niels Bergsland, Ondrej Dolezal, Eva Havrdova, Jan Krasensky, Michael G. Dwyer, Zdeněk Seidl, Deepa P. Ramasamy, Manuela Vaneckova, Dana Horakova
Published 2013-01-01

CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS

by Andrea Burgetova, Petr Dusek, Tomas Uher, Manuela Vaneckova, Martin Vejrazka, Romana Burgetova, Dana Horakova, Barbora Srpova, Marta Kalousova, Libuse Noskova, Katerina Levova, Jan Krasensky, Lukas Lambert
Published 2023-06-01

Establishing pathological cut-offs for lateral ventricular volume expansion rates

by Michael G. Dwyer, Jesper Hagemeier, Niels Bergsland, Dana Horakova, Jonathan R. Korn, Nasreen Khan, Tomas Uher, Jennie Medin, Diego Silva, Manuela Vaneckova, Eva Kubala Havrdova, Robert Zivadinov
Published 2018-01-01

Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients

by Tomas Uher, Kelly Fellows, Dana Horakova, Robert Zivadinov, Manuela Vaneckova, Lukas Sobisek, Michaela Tyblova, Zdenek Seidl, Jan Krasensky, Niels Bergsland, Bianca Weinstock-Guttman, Eva Havrdova, Murali Ramanathan
Published 2017-02-01

Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients

by Kelly Fellows, Tomas Uher, Richard W. Browne, Bianca Weinstock-Guttman, Dana Horakova, Helena Posova, Manuela Vaneckova, Zdenek Seidl, Jan Krasensky, Michaela Tyblova, Eva Havrdova, Robert Zivadinov, Murali Ramanathan
Published 2015-10-01

Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis

by Michaela Andelova, Tomas Uher, Jan Krasensky, Lukas Sobisek, Eliska Kusova, Barbora Srpova, Karolina Vodehnalova, Lucie Friedova, Jiri Motyl, Jana Lizrova Preiningerova, Eva Kubala Havrdova, Dana Horakova, Manuela Vaneckova
Published 2019-08-01

Validating atlas-based lesion disconnectomics in multiple sclerosis: A retrospective multi-centric study

by Veronica Ravano, Michaela Andelova, Mário João Fartaria, Mazen Fouad A-Wali Mahdi, Bénédicte Maréchal, Reto Meuli, Tomas Uher, Jan Krasensky, Manuela Vaneckova, Dana Horakova, Tobias Kober, Jonas Richiardi
Published 2021-01-01

Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis

by Jiri Motyl, Lucie Friedova, Manuela Vaneckova, Jan Krasensky, Balazs Lorincz, Jana Blahova Dusankova, Michaela Andelova, Tom A. Fuchs, Eva Kubala Havrdova, Ralph H. B. Benedict, Dana Horakova, Tomas Uher
Published 2021-03-01

Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ.

by Jana Libertinova, Eva Meluzinova, Ales Tomek, Dana Horakova, Ivana Kovarova, Vaclav Matoska, Simona Kumstyrova, Miroslav Zajac, Eva Hyncicova, Petra Liskova, Eva Houzvickova, Lukas Martinkovic, Martin Bojar, Eva Havrdova, Petr Marusic
Published 2017-01-01

Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab

by Petra Nytrova, Dominika Stastna, Adam Tesar, Adam Tesar, Ingrid Menkyova, Ingrid Menkyova, Helena Posova, Helena Koprivova, Veronika Mikulova, Jiri Hrdy, Gabriela Smela, Dana Horakova, Irena Rysankova, Kristyna Doleckova, Michaela Tyblova
Published 2023-06-01

Periventricular gradient of T1 tissue alterations in multiple sclerosis

by Manuela Vaneckova, Gian Franco Piredda, Michaela Andelova, Jan Krasensky, Tomas Uher, Barbora Srpova, Eva Kubala Havrdova, Karolina Vodehnalova, Dana Horakova, Tom Hilbert, Bénédicte Maréchal, Mário João Fartaria, Veronica Ravano, Tobias Kober
Published 2022-01-01